Tower Research Capital LLC (TRC) - SONNET BIOTHERAPEUTC HLDNG I ownership

Back to all holdings Add to watchlist

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R204. A total of 1 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2023$5,528
+276300.0%
11,281
+116.9%
0.00%–
Q1 2023$2
-81.8%
5,202
-44.2%
0.00%–
Q4 2022$11
-99.8%
9,324
+117.5%
0.00%–
Q3 2022$6,000–4,287–0.00%–
 Download
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q3 2023
NameSharesValueWeighting ↓
Ayrton Capital LLC 765,425$275,5530.99%
SABBY MANAGEMENT, LLC 1,215,534$437,5920.38%
Anson Funds Management LP 3,520,000$1,267,2000.10%
CVI Holdings, LLC 701,634$252,5880.10%
Walleye Capital LLC 1,664,595$599,2540.01%
Alyeska Investment Group, L.P. 848,000$305,2800.00%
Alyeska Investment Group, L.P. 951,806$342,6500.00%
BOOTHBAY FUND MANAGEMENT, LLC 136,231$49,0430.00%
IFP Advisors, Inc 142$2440.00%
BANK OF AMERICA CORP /DE/ 2$10.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders